Occurrence of lymphomas during ddC or ddC/zidovudine combination therapy in persons infected with HIV type 1 [3]

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue 5, 1996, Pages 464-465

  Moyle, G J ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CELL COUNT; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; LETTER; LYMPHOMA; PRIORITY JOURNAL; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030447929     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199612150-00012     Document Type: Letter

References (0)